Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Lenz Therapeutics and Arrotex Pharmaceuticals announced that they have reached an exclusive licensing and commercialization agreement for Vizz™ in the Australian and New Zealand markets.

Lenz Therapeutics and Arrotex Pharmaceuticals announced that they have reached an exclusive licensing and commercialization agreement for Vizz™ in the Australian and New Zealand markets.

老虎证券老虎证券2026/06/24 12:45
Show original
The signing of this agreement marks that the two companies will jointly advance the commercialization of Vizz™ in the aforementioned regions.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!